Local view for "http://purl.org/linkedpolitics/eu/plenary/2008-10-22-Speech-3-030"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2008-10-22"^^xsd:date2
dcterms:Is Part Of	lp_eu:Variations to the terms of marketing authorisations for medicinal products - Counterfeiting of medicinal products (debate)2
dcterms:Language	"pl"^^xsd:language2
lpv:document identification number	"en.20081022.2.3-030"2
lpv:hasSubsequent	lp_eu:2008-10-22-Speech-3-0312
lpv:speaker	lp:Genowefa Grabowska2
lpv:spokenAs	member; AFCO (2007-01-31--2009-07-13)3 member; PES (2004-07-20--2009-07-13)3 substitute; LIBE (2007-01-31--2009-07-13)3 unknown; Socjaldemokracja Polska (2004-07-20--2009-07-13)3 substitute; ENVI (2007-01-31--2009-07-13)3 substitute; DROI (2007-01-31--2009-07-13)3 member; Delegation to the ACP-EU Joint Parliamentary Assembly (2004-09-15--2009-07-13)3 substitute; Delegation to the EU-Kazakhstan, EU-Kyrgyzstan and EU-Uzbekistan Parliamentary Cooperation Committees, and for relations with Tajikistan, Turkmenistan and Mongolia (2004-09-15--2009-07-13)3
lpv:translated text	"Mr President, I would like to start by congratulating the rapporteur since, from the technical point of view, this report will provide greater safety for patients and greater safety for European Union citizens who need to take medicines. It is good that we are eliminating the difference between issuing marketing authorisation for a medicine, and the procedure for amending that decision. I would also like to refer to the words of Commissioner Verheugen and express my pleasure at the news that we will have new common regulations to combat counterfeiting and the illegal marketing of medicines. You made statements to the effect that you are doing everything to prevent counterfeit medicines from getting into the legal distribution network. My question is, what will happen outside the legal distribution network? Do the new regulations also cover this, or will the pharmaceutical industry just get a rap over the knuckles? My last question is as follows: do you plan to include a solution for greater pharmaceutical information for citizens in the new regulations?"@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph